Overview

Price chart · mood · technical indicators

CODX

Co-Diagnostics Incstock Healthcare

Medical Devices

$1.5785.03%Current Market Mood:Bearish

Market Mood

Price Range (1Y)

$1.35$46.50

Current: $1.57

Market Comparison

vs Healthcare Sector & Medical Devices Industry

CODX

-85.03%

1Y Performance

Fundamentals

Updated daily after market close

P/E ratio—Forward 15.36

EPS (TTM)$-35.2530.8% YoY

Profit margin0.0%HEALTHCARE

Market cap$5.6MMicro cap

Valuation

Forward P/E: 15.36
PEG ratio: 0.00
P/B: 0.27
P/S (TTM): 8.97
EV/EBITDA: 0.52

Profitability & growth

ROE (TTM): -125.9%
Operating margin: -2902.0%
Revenue growth YoY: 76.7%
Dividend yield: —
Beta: 1.26

Last earnings

Mar 19, 2026 · Estimate $-0.13 · Reported $-4.44

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Co-Diagnostics, Inc. Common Stock

Company profile

Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.

Classification

Sector: Healthcare
Industry: Medical Devices
Exchange: NASDAQ
Country: USA
Currency: USD

Company profile

HQ: 2401 S. FOOTHILL DR., SALT LAKE CITY, UT
Fiscal year end: December
Latest quarter: Dec 31, 2025

Market cap$5.6M

Shares outstanding$3.6M

52W high$46.50

52W low$1.35

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer

Overview

CODX

Market Comparison

Fundamentals

Valuation

Profitability & growth

News & Sentiment

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Inside Dubai's World Health Expo, Co-Diagnostics meets MENA lab leaders

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

India JV wins ISO seal to build cheaper Co-Dx home PCR devices

India grants license for CoSara PCR device; TB, HPV tests pending

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Co-Diagnostics (CODX) Downgraded to Hold by Maxim Group Today

Co-Diagnostics (CODX) Downgraded to Hold by Maxim Group Today

Co-Diagnostics Shares Transition to Over-the-Counter Trading

CODX Stock Price, Forecast & Analysis | CO-DIAGNOSTICS INC (NASDAQ:CODX)

Co-Diagnostics Faces Nasdaq Delisting After Bid Price Noncompliance

Co-Diagnostics (CODX) Price Target Increased by 2,900.00% to 38.25

Co-Diagnostics Received Notice of Delisting

Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market

Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform

About Co-Diagnostics, Inc. Common Stock

Classification

Company profile

CODX

Market Comparison

CODX Market Analysis

Overview

CODX

Market Comparison

Fundamentals

Valuation

Profitability & growth

News & Sentiment

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Inside Dubai's World Health Expo, Co-Diagnostics meets MENA lab leaders

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

India JV wins ISO seal to build cheaper Co-Dx home PCR devices

India grants license for CoSara PCR device; TB, HPV tests pending

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Co-Diagnostics (CODX) Downgraded to Hold by Maxim Group Today

Co-Diagnostics (CODX) Downgraded to Hold by Maxim Group Today

Co-Diagnostics Shares Transition to Over-the-Counter Trading

CODX Stock Price, Forecast & Analysis | CO-DIAGNOSTICS INC (NASDAQ:CODX)

Co-Diagnostics Faces Nasdaq Delisting After Bid Price Noncompliance

Co-Diagnostics (CODX) Price Target Increased by 2,900.00% to 38.25

Co-Diagnostics Received Notice of Delisting

Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market

Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform

About Co-Diagnostics, Inc. Common Stock

Classification

Company profile

CODX

Market Comparison